Jane Wei
Papers
2
Total Citations
11
H-Index
2
About
Dr. Jane Wei is a pioneering cardiac surgeon whose research focuses on advancing minimally invasive and hybrid approaches to coronary artery disease (CAD) treatment. Her work centers on robotic-assisted coronary artery bypass grafting (CABG) and hybrid coronary revascularization (HCR), which combine surgical and percutaneous techniques to optimize outcomes for patients with multivessel disease. In her landmark 2025 study, Dr. Wei examined the longitudinal safety and efficacy of HCR in a large cohort of 561 patients over an 11-year period, demonstrating that this paradigm-shifting approach offers durable benefits for complex CAD. Her 2022 paper on intensive care unit bypass for robotic-assisted single-vessel CABG has garnered 7 citations, highlighting its clinical relevance in streamlining perioperative care. With a predicted risk profile that underscores her focus on high-stakes patient populations, Dr. Wei's contributions are reshaping revascularization strategies, reducing recovery times, and expanding access to less invasive cardiac surgery. Her work stands at the intersection of surgical innovation and evidence-based practice, making her a leading voice in the evolution of modern coronary care.
Research Focus
Key Achievements
Top Papers
- 1
- 2